These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2961190)

  • 21. Ipratropium bromide and airways function in wheezy infants.
    Prendiville A; Green S; Silverman M
    Arch Dis Child; 1987 Apr; 62(4):397-400. PubMed ID: 2954510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide.
    Lulling J; Delwiche JP; Prignot J
    Respiration; 1981; 42(3):188-92. PubMed ID: 6458867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis.
    Matthys H; Hundenborn J; Daikeler G; Köhler D
    Respiration; 1985; 48(4):329-39. PubMed ID: 2934779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology and toxicology of ipratropium bromide.
    Cugell DW
    Am J Med; 1986 Nov; 81(5A):18-22. PubMed ID: 2947457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis.
    Jiang DH; Wang X; Liu LS; Ji DD; Zhang N
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5211-5216. PubMed ID: 29228436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
    Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological effects and determination of the morphological distribution of powder aerosols containing fenoterol hydrobromide and ipratropium bromide.
    Traunecker W; Muacevic G; Tilov T
    Respiration; 1984; 45(3):271-5. PubMed ID: 6235560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Thorax; 1979 Aug; 34(4):501-7. PubMed ID: 159510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome.
    Lee H; Arnon S; Silverman M
    Arch Dis Child Fetal Neonatal Ed; 1994 May; 70(3):F218-22. PubMed ID: 8198418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves].
    Illiano A; Tranfa CM; Giacomelli P; Cantatore D; Donato Di Paola RM; Marsico SA
    Arch Monaldi; 1981; 36(3):105-17. PubMed ID: 6216870
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance.
    Taylor RG; Pavia D; Agnew JE; Lopez-Vidriero MT; Newman SP; Lennard-Jones T; Clarke SW
    Thorax; 1986 Apr; 41(4):295-300. PubMed ID: 2943050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance.
    Tobin MJ; Hughes JA; Hutchison DC
    Eur J Respir Dis; 1984 Aug; 65(6):441-6. PubMed ID: 6236095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological effects of a combination of fenoterol hydrobromide and ipratropium bromide.
    Traunecker W; Muacevic G
    Respiration; 1986; 50(4):244-51. PubMed ID: 2950580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ipratropium bromide (atrovent) inhalation in chronic bronchitis.
    Kashyap S; Jindal SK; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):137-40. PubMed ID: 2943673
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ipratropium Bromide, an Anticholinergic Bronchodilator/Behavior of airways resistance in patients with reversible respiratory obstruction following inhalation of various doses of ipratropium bromide].
    Loddenkemper R
    Arzneimittelforschung; 1976; 26(5a):1017-20. PubMed ID: 134725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 40 mcg. and 400 mcg. of ipratropium bromide in obstructive lung disease.
    Dejaegher P; Demedts M; Rochette F; Van der Veken J
    Acta Clin Belg; 1984; 39(3):136-40. PubMed ID: 6237539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.